Japanese drugmaker Daiichi alerts India’s regulators vs potential Fortis stake sale
Japanese drugmaker Daiichi Sankyo has notified India’s regulators and bourses that any potential stake sale in Fortis Healthcare by its promoters, Malvinder and Shivinder Singh, would violate a Supreme Court order...To view the full article, register now.
Already a subscriber? Click here to view full article